H&S Invest Holding, chaired by Moncef Belkhayat, has announced two important steps in the process of preparing the family-owned group's listing on the Casablanca stock exchange:
1- The acquisition of Kosmopharm Pharmaceutical Laboratory following approval by the French competition authorities;
2- Consolidation of the Distribution and Industry Business Units through the legal merger of Dislog & Dislog industries.
source : Important : H&S Invest Holding announces 2 major deals - Infomédiaire